The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
Repurposing Drugs to Treat COVID-19 With Dr. David Fajgenbaum
Dr. David Fajgenbaum, physician-scientist and director of the Center for Cytokine Storm Treatment and Laboratory at the University of Pennsylvania, returns to the podcast to discuss the CORONA Project, a database of drugs being used to treat patients with COVID-19, and how these data are helping in the fight against the disease. Dr. Fajgenbaum is also the national bestselling author of Chasing My Cure, a memoir about his experience with Castleman disease, a rare, deadly illness with no known cure.
Optimizing Donor Choice and Improving Outcomes After Allogeneic HCT
In today’s episode, Dr. Daniel Weisdorf, hematologist/oncologist and bone marrow transplant physician at the University of Minnesota, discusses advances in allogeneic transplantation amid the expansion of donor registries globally and approaches to limit the morbidity of graft-versus-host-disease after allo HCT.
Accelerating Progress in Small Cell Lung Cancer
Dr. Lauren Byers, associate professor of Thoracic/Head & Neck Medical Oncology at the University of Texas MD Anderson Cancer Center, highlights a new study published in Cancer Cell that features a transformative new framework to classify small-cell lung cancer into four subtypes based on gene expression, paving the way for personalized treatment options.
Addressing Real-World Disparities With Real-World Solutions
Dr. Karen Winkfield, a radiation oncologist and Executive Director at the Meharry-Vanderbilt Alliance, and Jeanne Regnante, Chief Health Equity and Diversity Officer at the LUNGevity Foundation, discuss a new actionable framework published in JCO Oncology Practice that addresses disparities across the cancer care continuum in medically underserved communities in the United States.
Highlights From #GU21 With Dr. Stephen Boorjian
In today’s episode, Dr. Stephen Boorjian, professor of urology at the Mayo Clinic, in Minnesota, and chair of the GU Cancers Symposium, discusses key advances across GU malignancies.
#GU21: Improving Outcomes for Patients With Prostate Cancer
In today’s episode, Dr. Neeraj Agarwal, medical oncologist and director of the Genitourinary Oncology Program at the University of Utah’s Huntsman Cancer Institute, highlights recent advances in prostate cancer research.